According to BlockBeats news on October 2, Injective announced the launch of an on-chain Pre-IPO market, aimed at allowing global investors to trade synthetic assets of major private companies, including OpenAI. This new product allows users to engage in Margin Trading with up to 5 times leverage directly on the valuations of private companies through Injective.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Injective launches on-chain Pre-IPO market
According to BlockBeats news on October 2, Injective announced the launch of an on-chain Pre-IPO market, aimed at allowing global investors to trade synthetic assets of major private companies, including OpenAI. This new product allows users to engage in Margin Trading with up to 5 times leverage directly on the valuations of private companies through Injective.